Drug Monitoring, Opiates Expanded, Quantitative, Urine
Also known as: Pain Management, Prescription Drug Monitoring
Use
A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites within the opiate drug class facilitates enhanced patient care. The test uses definitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance with treatment strategies and ensuring non‑diversion for illicit purposes. Urine (or oral fluid) is the specimen of choice. Quantitative values should not be used to assess drug dose due to extensive metabolism and urinary excretion.
Special Instructions
Not provided.
Limitations
Not available for New York patient testing. Quantitative results cannot be used to assess drug dose. Requires medMATCH if prescribed‑drug match verification is desired.
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
10 mL
Minimum Volume
9 mL
Container
plastic urine container
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |